Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents; D002462:Cell Membrane / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000494:pharmacology*; D003630:Daunorubicin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004355:Drug Stability; D004611:Ellipticines / Q000378:metabolism / Q000494:pharmacology*; D007939:Leukemia L1210 / Q000378:metabolism / Q000473:pathology*; D008247:Lysosomes / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D013997:Time Factors
D000470:Alkaloids; D000970:Antineoplastic Agents; D004611:Ellipticines; D004247:DNA; D003630:Daunorubicin